Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Ost

Showing results (31-40 of 334) with videos related to

Pageof 34
Sort By:
Journal of Applied Clinical Medical Physics|May 12, 2023
Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapyWilleke Danckaert, Piet Ost, Carlos De Wagter
European Urology|September 17, 2011
Intensity-modulated radiotherapy: the gold standard for postprostatectomy irradiation?Alberto Bossi, Gert De Meerleer, Piet Ost
European Urology|August 28, 2020
When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging ModalitiesNora Sundahl, Silke Gillessen, Christopher Sweeney, et al.
Current Opinion in Urology|August 18, 2017
Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancerElise De Bleser, Phuoc T Tran, Piet Ost
European Urology|September 26, 2021
Stereotactic Radiotherapy for Oligoprogressive Disease: A New Frontier in Kidney CancerShankar Siva, Piet Ost, Nicholas Zaorsky, et al.
BJU International|November 27, 2025
Authors' reply to: comment on 'Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer'Lies Van den Eynde, Piet Ost, Nicolaas Lumen
European Urology Focus|March 3, 2019
Adding Colour to the Grey Zone of Advanced Prostate CancerDeclan G Murphy, Anwar R Padhani, Piet Ost
European Journal of Cancer (Oxford, England : 1990)|February 28, 2012
Salvage radiotherapy: a plea for dose-escalation with intensity-modulated radiotherapyPiet Ost, Cesare Cozzarini, Alberto Bossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2019
Has the PROPHECY of AR-V7 Been Fulfilled?Bram De Laere, Piet Ost, Henrik Grönberg, et al.
Expert Review of Anticancer Therapy|December 30, 2017
Pembrolizumab for the treatment of bladder cancerNora Sundahl, Sylvie Rottey, Daan De Maeseneer, et al.
Pageof 34

Showing results (31-40 of 334) with videos related to

Sort By:
Pageof 34
Journal of Applied Clinical Medical Physics|May 12, 2023
Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapyWilleke Danckaert, Piet Ost, Carlos De Wagter
European Urology|September 17, 2011
Intensity-modulated radiotherapy: the gold standard for postprostatectomy irradiation?Alberto Bossi, Gert De Meerleer, Piet Ost
European Urology|August 28, 2020
When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging ModalitiesNora Sundahl, Silke Gillessen, Christopher Sweeney, et al.
Current Opinion in Urology|August 18, 2017
Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancerElise De Bleser, Phuoc T Tran, Piet Ost
European Urology|September 26, 2021
Stereotactic Radiotherapy for Oligoprogressive Disease: A New Frontier in Kidney CancerShankar Siva, Piet Ost, Nicholas Zaorsky, et al.
BJU International|November 27, 2025
Authors' reply to: comment on 'Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer'Lies Van den Eynde, Piet Ost, Nicolaas Lumen
European Urology Focus|March 3, 2019
Adding Colour to the Grey Zone of Advanced Prostate CancerDeclan G Murphy, Anwar R Padhani, Piet Ost
European Journal of Cancer (Oxford, England : 1990)|February 28, 2012
Salvage radiotherapy: a plea for dose-escalation with intensity-modulated radiotherapyPiet Ost, Cesare Cozzarini, Alberto Bossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2019
Has the PROPHECY of AR-V7 Been Fulfilled?Bram De Laere, Piet Ost, Henrik Grönberg, et al.
Expert Review of Anticancer Therapy|December 30, 2017
Pembrolizumab for the treatment of bladder cancerNora Sundahl, Sylvie Rottey, Daan De Maeseneer, et al.
Pageof 34